Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.5812 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.62314 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.39142 | 78 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.24184 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.98217 | 82 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.58267 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.28063 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.26657 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.01341 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.53268 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.03604 | 83 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.52535 | 79 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.65306 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.6183 | 80 |